000 01374 a2200421 4500
005 20250511212425.0
264 0 _c19911031
008 199110s 0 0 eng d
022 _a0007-0920
024 7 _a10.1038/bjc.1991.356
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMansi, J L
245 0 0 _aA phase II clinical and pharmacokinetic study of Lonidamine in patients with advanced breast cancer.
_h[electronic resource]
260 _bBritish journal of cancer
_cSep 1991
300 _a593-7 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenosine Triphosphate
_xmetabolism
650 0 4 _aAntineoplastic Agents
_xtoxicity
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aIndazoles
_xpharmacokinetics
650 0 4 _aMagnetic Resonance Spectroscopy
_xmethods
650 0 4 _aMenopause
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aReceptors, Estrogen
_xanalysis
700 1 _ade Graeff, A
700 1 _aNewell, D R
700 1 _aGlaholm, J
700 1 _aButton, D
700 1 _aLeach, M O
700 1 _aPayne, G
700 1 _aSmith, I E
773 0 _tBritish journal of cancer
_gvol. 64
_gno. 3
_gp. 593-7
856 4 0 _uhttps://doi.org/10.1038/bjc.1991.356
_zAvailable from publisher's website
999 _c1917401
_d1917401